Kilter Group’s CureVac CVAC Stock Holding History

Kilter Group’s Portfolio CVAC Stock Details CVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-33	Closed	-$178	–	1428
2025 Q3	$178	Buy	+33	New	+$179	﹤0.01%	1184

Other funds holding CVAC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OBAM

ODDO BHF Asset Management Paris, France $2.16B AUM 43.32% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Kilter Group's CVAC Position: Q4 2025 in Review

Kilter Group sold out of CureVac (CVAC) in Q4 2025, closing a stake of 33 shares — an estimated $178 sold.

Kilter Group first reported a position in CVAC in Q3 2025 and held it in 1 quarter. The position peaked at $178 in Q3 2025. 57 funds tracked by Wall St. Rank hold CVAC as of Q4 2025.

Kilter Group reported no remaining CureVac position as of Q4 2025 after selling out during the quarter.
Kilter Group sold 33 CureVac shares in Q4 2025, an estimated $178.
Kilter Group first reported a position in CureVac in Q3 2025 and held it in 1 quarter.
Kilter Group's CureVac position peaked at $178 in Q3 2025.
57 funds tracked by Wall St. Rank held CureVac as of Q4 2025.

Based on Kilter Group's 13F filing for Q4 2025, filed 13 Feb 2026.